Sheppard Mullin Richter & Hampton LLP | USA | 14 Mar 2024
The U.S. Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) recently released…
Sheppard Mullin Richter & Hampton LLP | USA | 8 Mar 2024
On February 16, the U. S. District Court for the District of Oregon struck down the State’s drug price transparency law—The Prescription Drug Price…
Audio
Sheppard Mullin Richter & Hampton LLP | USA | 7 Mar 2024
Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day. Our digital health legal team…
Sheppard Mullin Richter & Hampton LLP | USA | 6 Mar 2024
On March 5, 2024, the Federal Trade Commission (“the FTC”) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on…
Sheppard Mullin Richter & Hampton LLP | USA | 28 Feb 2024
The United States District Court for the Eastern District of Virginia recently dismissed an appeal by the Pharmaceutical Coalition for Patient Access…
Sheppard Mullin Richter & Hampton LLP | USA | 26 Feb 2024
AI is here to stay. The development and use of artificial intelligence (“AI”) is rapidly growing in the healthcare landscape with no signs of slowing…
Audio
Sheppard Mullin Richter & Hampton LLP | USA | 14 Feb 2024
Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day. Our digital health legal team…
Sheppard Mullin Richter & Hampton LLP | USA | 13 Feb 2024
This article briefly analyzes recent Patent Trial and Appeal Board (“PTAB”) decisions on medical technology incorporating artificial intelligence…